TNC
Tenascin
Also known as: DFNA56, HXB, MGC167029, TENA_HUMAN, TN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P24821
- Gene
- TNC
- Ensembl
- ENSG00000041982
- Chromosome
- 9
- Canonical length
- 2201 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to extracellular matrix
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
This gene encodes an extracellular matrix protein with a spatially and temporally restricted tissue distribution. This protein is homohexameric with disulfide-linked subunits, and contains multiple EGF-like and fibronectin type-III domains. It is implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity, and neuronal regeneration. [provided by RefSeq, Jul 2011]
Canonical amino-acid sequenceUniProt
2201 residues, UniProt reviewed canonical sequence.
>P24821|TNC
1 MGAMTQLLAG VFLAFLALAT EGGVLKKVIR HKRQSGVNAT LPEENQPVVF NHVYNIKLPV
61 GSQCSVDLES ASGEKDLAPP SEPSESFQEH TVDGENQIVF THRINIPRRA CGCAAAPDVK
121 ELLSRLEELE NLVSSLREQC TAGAGCCLQP ATGRLDTRPF CSGRGNFSTE GCGCVCEPGW
181 KGPNCSEPEC PGNCHLRGRC IDGQCICDDG FTGEDCSQLA CPSDCNDQGK CVNGVCICFE
241 GYAGADCSRE ICPVPCSEEH GTCVDGLCVC HDGFAGDDCN KPLCLNNCYN RGRCVENECV
301 CDEGFTGEDC SELICPNDCF DRGRCINGTC YCEEGFTGED CGKPTCPHAC HTQGRCEEGQ
361 CVCDEGFAGV DCSEKRCPAD CHNRGRCVDG RCECDDGFTG ADCGELKCPN GCSGHGRCVN
421 GQCVCDEGYT GEDCSQLRCP NDCHSRGRCV EGKCVCEQGF KGYDCSDMSC PNDCHQHGRC
481 VNGMCVCDDG YTGEDCRDRQ CPRDCSNRGL CVDGQCVCED GFTGPDCAEL SCPNDCHGQG
541 RCVNGQCVCH EGFMGKDCKE QRCPSDCHGQ GRCVDGQCIC HEGFTGLDCG QHSCPSDCNN
601 LGQCVSGRCI CNEGYSGEDC SEVSPPKDLV VTEVTEETVN LAWDNEMRVT EYLVVYTPTH
661 EGGLEMQFRV PGDQTSTIIQ ELEPGVEYFI RVFAILENKK SIPVSARVAT YLPAPEGLKF
721 KSIKETSVEV EWDPLDIAFE TWEIIFRNMN KEDEGEITKS LRRPETSYRQ TGLAPGQEYE
781 ISLHIVKNNT RGPGLKRVTT TRLDAPSQIE VKDVTDTTAL ITWFKPLAEI DGIELTYGIK
841 DVPGDRTTID LTEDENQYSI GNLKPDTEYE VSLISRRGDM SSNPAKETFT TGLDAPRNLR
901 RVSQTDNSIT LEWRNGKAAI DSYRIKYAPI SGGDHAEVDV PKSQQATTKT TLTGLRPGTE
961 YGIGVSAVKE DKESNPATIN AATELDTPKD LQVSETAETS LTLLWKTPLA KFDRYRLNYS
1021 LPTGQWVGVQ LPRNTTSYVL RGLEPGQEYN VLLTAEKGRH KSKPARVKAS TEQAPELENL
1081 TVTEVGWDGL RLNWTAADQA YEHFIIQVQE ANKVEAARNL TVPGSLRAVD IPGLKAATPY
1141 TVSIYGVIQG YRTPVLSAEA STGETPNLGE VVVAEVGWDA LKLNWTAPEG AYEYFFIQVQ
1201 EADTVEAAQN LTVPGGLRST DLPGLKAATH YTITIRGVTQ DFSTTPLSVE VLTEEVPDMG
1261 NLTVTEVSWD ALRLNWTTPD GTYDQFTIQV QEADQVEEAH NLTVPGSLRS MEIPGLRAGT
1321 PYTVTLHGEV RGHSTRPLAV EVVTEDLPQL GDLAVSEVGW DGLRLNWTAA DNAYEHFVIQ
1381 VQEVNKVEAA QNLTLPGSLR AVDIPGLEAA TPYRVSIYGV IRGYRTPVLS AEASTAKEPE
1441 IGNLNVSDIT PESFNLSWMA TDGIFETFTI EIIDSNRLLE TVEYNISGAE RTAHISGLPP
1501 STDFIVYLSG LAPSIRTKTI SATATTEALP LLENLTISDI NPYGFTVSWM ASENAFDSFL
1561 VTVVDSGKLL DPQEFTLSGT QRKLELRGLI TGIGYEVMVS GFTQGHQTKP LRAEIVTEAE
1621 PEVDNLLVSD ATPDGFRLSW TADEGVFDNF VLKIRDTKKQ SEPLEITLLA PERTRDITGL
1681 REATEYEIEL YGISKGRRSQ TVSAIATTAM GSPKEVIFSD ITENSATVSW RAPTAQVESF
1741 RITYVPITGG TPSMVTVDGT KTQTRLVKLI PGVEYLVSII AMKGFEESEP VSGSFTTALD
1801 GPSGLVTANI TDSEALARWQ PAIATVDSYV ISYTGEKVPE ITRTVSGNTV EYALTDLEPA
1861 TEYTLRIFAE KGPQKSSTIT AKFTTDLDSP RDLTATEVQS ETALLTWRPP RASVTGYLLV
1921 YESVDGTVKE VIVGPDTTSY SLADLSPSTH YTAKIQALNG PLRSNMIQTI FTTIGLLYPF
1981 PKDCSQAMLN GDTTSGLYTI YLNGDKAEAL EVFCDMTSDG GGWIVFLRRK NGRENFYQNW
2041 KAYAAGFGDR REEFWLGLDN LNKITAQGQY ELRVDLRDHG ETAFAVYDKF SVGDAKTRYK
2101 LKVEGYSGTA GDSMAYHNGR SFSTFDKDTD SAITNCALSY KGAFWYRNCH RVNLMGRYGD
2161 NNHSQGVNWF HWKGHEHSIQ FAEMKLRPSN FRNLEGRRKR ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 447 nTPM
Expression across tissuesHPA
Tissue
- smooth muscle: 447 nTPM
- blood vessel: 346 nTPM
- appendix: 209 nTPM
- colon: 161 nTPM
- urinary bladder: 110 nTPM
- endometrium: 91 nTPM
Single-cell type
- smooth muscle cells: 691 nCPM
- vascular smooth muscle cells: 681 nCPM
- endometrial secretory cells: 663 nCPM
- astrocytes: 621 nCPM
- epididymal basal cells: 617 nCPM
- salivary myoepithelial cells: 386 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 171 nTPM
- midbrain: 108 nTPM
- hypothalamus: 87 nTPM
- pons: 72 nTPM
- basal ganglia: 71 nTPM
- medulla oblongata: 68 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNC.
Disease | AllUniProt
Conditions TNC is implicated in, by any mechanism.
- Deafness, autosomal dominant, 56 (DFNA56) MIM:615629
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 655 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal dominant nonsyndromic hearing loss 56
- TNC-related disorder
Disease | ImmuneIEDB
Conditions an epitope on TNC was assayed in.
- rheumatoid arthritis B and T cell
- glioblastoma T cell
- osteoarthritis B cell
- systemic juvenile rheumatoid arthritis T cell
ReferencesPubMed · IEDB
Publications for TNC from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Similarities of an autoantigen in aneurysmal disease of the human abdominal aorta to a 36-kDa microfibril-associated bovine aortic glycoprotein.
1995 · Biochem Biophys Res Commun · RCR 0.9 · 32 citations - Autoantibodies common in patients with gastrointestinal diseases are not found in patients with endometriosis: A cross-sectional study.
2019 · Eur J Obstet Gynecol Reprod Biol · RCR 0.6 · 8 citations
Reference: B cellIEDB
5 publications
- In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells.
2021 · Ann Rheum Dis · RCR 6.2 · 109 citations - Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis.
2021 · JCI Insight · RCR 2.8 · 43 citations - Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
2016 · Ann Rheum Dis · RCR 2.4 · 62 citations - Association of Distinct Fine Specificities of Anti-Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis.
2017 · Arthritis Rheumatol · RCR 2.1 · 47 citations - Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.
2020 · Arthritis Rheumatol · RCR 1.7 · 30 citations
Reference: T cellIEDB
5 publications
- Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis.
2021 · Sci Rep · RCR 1.4 · 24 citations - Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.
2006 · Arthritis Res Ther · RCR 0.6 · 27 citations - Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma.
2022 · Clin Cancer Res · RCR 0.6 · 10 citations - Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target.
2003 · J Rheumatol · RCR 0.1 · 6 citations - The molecular basis of T cell receptor recognition of citrullinated tenascin-C presented by HLA-DR4.
2025 · J Biol Chem · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.08
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bud outgrowth involved in lung branching
- cell adhesion
- cellular response to prostaglandin D stimulus
- cellular response to retinoic acid
- cellular response to vitamin D
- mesenchymal-epithelial cell signaling involved in prostate gland development
- morphogenesis of an epithelium
- negative regulation of cell adhesion
- neuromuscular junction development
- odontogenesis of dentin-containing tooth
- osteoblast differentiation
- peripheral nervous system axon regeneration
- positive regulation of cell population proliferation
- positive regulation of gene expression
- prostate gland epithelium morphogenesis
- regulation of cell adhesion
- regulation of cell growth
- regulation of cell migration
- regulation of inflammatory response
- response to ethanol
- response to fibroblast growth factor
- response to mechanical stimulus
- response to wounding
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-like domain
- Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain
- Fibronectin type III
- Epidermal growth factor-like domain, extracellular
- Immunoglobulin-like fold
- Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1
- Fibrinogen-like, C-terminal
- Fibronectin type III superfamily
- Tenascin, EGF-like domain
- Extracellular Matrix Regulatory Proteins
- Fibronectin type III domain
- Fibrinogen beta and gamma chains, C-terminal globular domain
- EGF-like domain
- Tenascin EGF domain
- Teneurin-like EGF domain
- Teneurin EGF domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNC as an antibody target. Whether an autoantibody or antibody against TNC could matter depends on whether native TNC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNC is annotated as secreted, so native TNC circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TNC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...